M. Baekelandt

1.9k total citations
55 papers, 1.4k citations indexed

About

M. Baekelandt is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, M. Baekelandt has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Reproductive Medicine, 18 papers in Oncology and 13 papers in Obstetrics and Gynecology. Recurrent topics in M. Baekelandt's work include Ovarian cancer diagnosis and treatment (28 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Intraperitoneal and Appendiceal Malignancies (8 papers). M. Baekelandt is often cited by papers focused on Ovarian cancer diagnosis and treatment (28 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Intraperitoneal and Appendiceal Malignancies (8 papers). M. Baekelandt collaborates with scholars based in Norway, Belgium and Switzerland. M. Baekelandt's co-authors include Gunnar B. Kristensen, Ruth Holm, Amin Makar, Claes G. Tropé, M. Castiglione, J. M. Nesland, Claes G. Tropé, Jahn M. Nesland, Vera M. Abeler and P. Buytaert and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

M. Baekelandt

54 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Baekelandt Norway 24 664 525 437 426 308 55 1.4k
Toshio Hirakawa Japan 25 893 1.3× 339 0.6× 573 1.3× 524 1.2× 288 0.9× 55 1.8k
A.G.J. van der Zee Netherlands 24 434 0.7× 528 1.0× 593 1.4× 318 0.7× 301 1.0× 53 1.6k
A. Pfleiderer Germany 23 509 0.8× 424 0.8× 435 1.0× 365 0.9× 250 0.8× 105 1.5k
Yasuyuki Hirashima Japan 26 362 0.5× 542 1.0× 557 1.3× 455 1.1× 319 1.0× 81 1.8k
Salvatore Lopez Italy 25 619 0.9× 551 1.0× 369 0.8× 606 1.4× 197 0.6× 89 1.6k
Shoji Kodama Japan 20 1.5k 2.2× 806 1.5× 474 1.1× 900 2.1× 473 1.5× 40 2.6k
Hironori Tashiro Japan 21 457 0.7× 355 0.7× 572 1.3× 250 0.6× 198 0.6× 37 1.4k
Masato Nishida Japan 24 968 1.5× 276 0.5× 405 0.9× 888 2.1× 492 1.6× 96 2.1k
Joanne Rutgers United States 23 555 0.8× 391 0.7× 381 0.9× 848 2.0× 341 1.1× 53 1.8k
J. J. Kavanagh United States 17 545 0.8× 396 0.8× 308 0.7× 232 0.5× 303 1.0× 50 1.2k

Countries citing papers authored by M. Baekelandt

Since Specialization
Citations

This map shows the geographic impact of M. Baekelandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Baekelandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Baekelandt more than expected).

Fields of papers citing papers by M. Baekelandt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Baekelandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Baekelandt. The network helps show where M. Baekelandt may publish in the future.

Co-authorship network of co-authors of M. Baekelandt

This figure shows the co-authorship network connecting the top 25 collaborators of M. Baekelandt. A scholar is included among the top collaborators of M. Baekelandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Baekelandt. M. Baekelandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baekelandt, M., et al.. (2010). Limitations of tissue microarrays compared with whole tissue sections in survival analysis. Oncology Letters. 1(5). 827–831. 34 indexed citations
2.
Baekelandt, M. & M. Castiglione. (2009). Endometrial carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of Oncology. 20. iv29–iv31. 65 indexed citations
3.
Kærn, J., et al.. (2008). Chemotherapy versus hormonal treatment in patients with platinum and taxane resistant ovarian cancer: A NSGO study. Journal of Clinical Oncology. 26(15_suppl). 5508–5508. 8 indexed citations
4.
Davidson, Ben, M. Baekelandt, & Ie‐Ming Shih. (2007). MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells. Diagnostic Cytopathology. 35(12). 756–760. 33 indexed citations
5.
Baekelandt, M., et al.. (2006). The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma. Gynecologic Oncology. 103(3). 831–840. 25 indexed citations
7.
Mebis, Jeroen, Hendrik De Raeve, M. Baekelandt, Wiebren Tjalma, & J. B. Vermorken. (2004). Primary ovarian small cell carcinoma of the pulmonary type: a case report and review of the literature.. PubMed. 25(2). 239–41. 22 indexed citations
8.
Davidson, Ben, Iris Goldberg, M. Baekelandt, et al.. (2004). The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions. Clinical & Experimental Metastasis. 21(3). 191–199. 23 indexed citations
9.
Baekelandt, M.. (2003). The potential role of neoadjuvant chemotherapy in advanced ovarian cancer. International Journal of Gynecological Cancer. 13(s2). 163–168. 25 indexed citations
10.
Baekelandt, M.. (2002). Hormonal treatment of endometrial carcinoma. Expert Review of Anticancer Therapy. 2(1). 106–112. 3 indexed citations
11.
Baay, Marc, Wiebren Tjalma, Joost Weyler, et al.. (2001). Prevalence of Human Papillomavirus in Elderly Women with Cervical Cancer. Gynecologic and Obstetric Investigation. 52(4). 248–251. 8 indexed citations
12.
Baekelandt, M., Gunnar B. Kristensen, Claes G. Tropé, Jahn M. Nesland, & Ruth Holm. (2000). Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer.. PubMed. 19(5C). 4469–74. 26 indexed citations
13.
Baekelandt, M., Ruth Holm, Claes G. Tropé, J. M. Nesland, & Gitte Kristensen. (1999). The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer. Annals of Oncology. 10(11). 1335–1341. 31 indexed citations
14.
Lehne, Gustav, Erkki Elonen, M. Baekelandt, Torben Skovsgaard, & Curt Peterson. (1998). Challenging Drug Resistance in Cancer Therapy: Review of the First Nordic Conference on Chemoresistance in Cancer Treatment, October 9th and 10th, 1997. Acta Oncologica. 37(5). 431–439. 18 indexed citations
15.
Makar, Amin, et al.. (1995). The Prognostic Significance of Residual Disease, FIGO Substage, Tumor Histology, and Grade in Patients with FIGO Stage III Ovarian Cancer. Gynecologic Oncology. 56(2). 175–180. 187 indexed citations
16.
Baekelandt, M., et al.. (1993). Primary adenocarcinoma of the fallopian tube. Review of the literature. International Journal of Gynecological Cancer. 3(2). 65–71. 28 indexed citations
17.
Hellemans, Peter, et al.. (1992). Preliminary results with the use of the ROM-check immunoassay in the early detection of rupture of the amniotic membranes. European Journal of Obstetrics & Gynecology and Reproductive Biology. 43(3). 173–179. 12 indexed citations
18.
Baekelandt, M., et al.. (1991). Occult prostatic abscess detected by transrectal sonography and computed tomography. Case report.. PubMed. 74(3). 217–9. 1 indexed citations
19.
Baekelandt, M., et al.. (1991). Spontaneous retroperitoneal renal hemorrhage: imaging and angiographic findings in five patients.. PubMed. 74(3). 213–6. 1 indexed citations
20.
Renier, Marine, et al.. (1989). Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes and low platelets in severe preeclampsia. International Journal of Gynecology & Obstetrics. 29(2). 197–198. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026